The combination of Bifidobacterium breve with non-digestible oligosaccharides suppresses airway inflammation in a murine model for chronic asthma

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1842, Issue 4, 2014, Pages 573-583

  Sagar, Seil ^a,b   Vos, Arjan P ^a,b   Morgan, Mary E ^a   Garssen, Johan ^a,b   Georgiou, Niki A ^b   Boon, Louis ^c   Kraneveld, Aletta D ^a   Folkerts, Gert ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b DANONE RESEARCH   (Netherlands)

^c BIOCEROS   (Netherlands)

Author keywords

Airway inflammation; Allergic asthma; Bifidobacterium breve; Murine asthma model; Regulatory T cell; Transcription factor

Indexed keywords

CYTOKINE; INTERLEUKIN 10; MESSENGER RNA; OLIGOSACCHARIDE; OVALBUMIN; PATTERN RECOGNITION RECEPTOR; PROBIOTIC AGENT; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP3;

AIRWAY REMODELING; ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL STRAIN; BIFIDOBACTERIUM BREVE; CD4+ CD25+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFICACY; FLOW CYTOMETRY; HELPER CELL; LUNG PARENCHYMA; MALE; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; RESPIRATORY TRACT INFLAMMATION; T LYMPHOCYTE ACTIVATION;

AIRWAY INFLAMMATION; ALLERGIC ASTHMA; BIFIDOBACTERIUM BREVE; MURINE ASTHMA MODEL; REGULATORY T CELL; TRANSCRIPTION FACTOR;

AIRWAY REMODELING; ANIMALS; ASTHMA; BIFIDOBACTERIUM; CHRONIC DISEASE; CYTOKINES; DISEASE MODELS, ANIMAL; FORKHEAD TRANSCRIPTION FACTORS; MALE; MAST CELLS; MICE; MICE, INBRED BALB C; OLIGOSACCHARIDES; RECEPTORS, PATTERN RECOGNITION; RNA, MESSENGER; TH2 CELLS;

EID: 84893458084     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2014.01.005     Document Type: Article

References (53)

1. McMillan S.J., Lloyd C.M. Prolonged allergen challenge in mice leads to persistent airway remodelling. Clin. Exp. Allergy 2004, 34:497-507.
2. Shifren A., Witt C., Christie C., Castro M. Mechanisms of remodeling in asthmatic airways. J. Allergy (Cairo) 2012, 316049.
3. Bai T.R., Knight D.A. Structural changes in the airways in asthma: observations and consequences. Clin. Sci. (Lond.) 2005, 108:463-477.
4. Galli S.J., Tsai M., Piliponsky A.M. The development of allergic inflammation. Nature 2008, 454:445-454.
5. Pejler G., Ronnberg E., Waern I., Wernersson S. Mast cell proteases: multifaceted regulators of inflammatory disease. Blood 2010, 115:4981-4990.
6. Sugimoto K., Kudo M., Sundaram A., Ren X., Huang K., Bernstein X., Wang Y., Raymond W.W., Erle D.J., Abrink M., Caughey G.H., Huang X., Sheppard D. The alphavbeta6 integrin modulates airway hyperresponsiveness in mice by regulating intraepithelial mast cells. J. Clin. Invest. 2012, 122:748-758.
7. Fahy J.V. Eosinophilic and neutrophilic inflammation in asthma: insights from clinical studies. Proc. Am. Thorac. Soc. 2009, 6:256-259.
8. Holgate S.T. Innate and adaptive immune responses in asthma. Nat. Med. 2012, 18:673-683.
9. Barnes P.J. New therapies for asthma: is there any progress?. Trends Pharmacol. Sci. 2010, 31:335-343.
10. Tamm M., Richards D.H., Beghe B., Fabbri L. Inhaled corticosteroid and long-acting beta2-agonist pharmacological profiles: effective asthma therapy in practice. Respir. Med. 2012, 106(Suppl. 1):S9-S19.
11. Nials A.T., Uddin S. Mouse models of allergic asthma: acute and chronic allergen challenge. Dis. Model. Mech. 2008, 1:213-220.
12. Vieira W.A., Pretorius E. The impact of asthma on the gastrointestinal tract (GIT). J. Asthma Allergy 2010, 3:123-130.
13. Maslowski K.M., Mackay C.R. Diet, gut microbiota and immune responses. Nat. Immunol. 2011, 12:5-9.
14. Noverr M.C., Huffnagle G.B. Does the microbiota regulate immune responses outside the gut?. Trends Microbiol. 2004, 12:562-568.
15. Kranich J., Maslowski K.M., Mackay C.R. Commensal flora and the regulation of inflammatory and autoimmune responses. Semin. Immunol. 2011, 23:139-145.
16. Vyas U., Ranganathan N. Probiotics, prebiotics, and synbiotics: gut and beyond. Gastroenterol. Res. Pract. 2012, 872716.
17. Gourbeyre P., Denery S., Bodinier M. Probiotics, prebiotics, and synbiotics: impact on the gut immune system and allergic reactions. J. Leukoc. Biol. 2011, 89:685-695.
18. Schouten B., van Esch B.C., Hofman G.A., van Doorn S.A., Knol J., Nauta A.J., Garssen J., Willemsen L.E., Knippels L.M. Cow milk allergy symptoms are reduced in mice fed dietary synbiotics during oral sensitization with whey. J. Nutr. 2009, 139:1398-1403.
19. van de Pol M.A., Lutter R., Smids B.S., Weersink E.J., van der Zee J.S. Synbiotics reduce allergen-induced T-helper 2 response and improve peak expiratory flow in allergic asthmatics. Allergy 2011, 66:39-47.
20. van der Aa L.B., van Aalderen W.M., Heymans H.S., Henk Sillevis Smitt J., Nauta A.J., Knippels L.M., Ben Amor K., Sprikkelman A.B. Synbiotics prevent asthma-like symptoms in infants with atopic dermatitis. Allergy 2011, 66:170-177.
21. Vos A.P., Haarman M., Buco A., Govers M., Knol J., Garssen J., Stahl B., Boehm G., M'Rabet L. A specific prebiotic oligosaccharide mixture stimulates delayed-type hypersensitivity in a murine influenza vaccination model. Int. Immunopharmacol. 2006, 6:1277-1286.
22. Vos A.P., Haarman M., van Ginkel J.W., Knol J., Garssen J., Stahl B., Boehm G., M'Rabet L. Dietary supplementation of neutral and acidic oligosaccharides enhances Th1-dependent vaccination responses in mice. Pediatr. Allergy Immunol. 2007, 18:304-312.
23. Vos A.P., van Esch B.C., Stahl B., M'Rabet L., Folkerts G., Nijkamp F.P., Garssen J. Dietary supplementation with specific oligosaccharide mixtures decreases parameters of allergic asthma in mice. Int. Immunopharmacol. 2007, 7:1582-1587.
24. Kalliomaki M., Antoine J.M., Herz U., Rijkers G.T., Wells J.M., Mercenier A. Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of allergic diseases by probiotics. J. Nutr. 2010, 140:713S-721S.
25. West A.P., Koblansky A.A., Ghosh S. Recognition and signaling by Toll-like receptors. Annu. Rev. Cell Dev. Biol. 2006, 22:409-437.
26. Chen K., Xiang Y., Yao X., Liu Y., Gong W., Yoshimura T., Wang J.M. The active contribution of Toll-like receptors to allergic airway inflammation. Int. Immunopharmacol. 2011, 11:1391-1398.
27. Uehara A., Fujimoto Y., Fukase K., Takada H. Various human epithelial cells express functional Toll-like receptors, NOD1 and NOD2 to produce anti-microbial peptides, but not proinflammatory cytokines. Mol. Immunol. 2007, 44:3100-3111.
28. Iwasaki A., Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 2004, 5:987-995.
29. Hammad H., Lambrecht B.N. Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma. Nat. Rev. Immunol. 2008, 8:193-204.
30. Barnes P.J. The cytokine network in chronic obstructive pulmonary disease. Am. J. Respir. Cell Mol. Biol. 2009, 41:631-638.
31. Boyce J.A., Bochner B., Finkelman F.D., Rothenberg M.E. Advances in mechanisms of asthma, allergy, and immunology in 2011. J. Allergy Clin. Immunol. 2012, 129:335-341.
32. Heine H. TLRs, NLRs and RLRs: innate sensors and their impact on allergic diseases-a current view. Immunol. Lett. 2011, 139:14-24.
33. Eder W., Klimecki W., Yu L., von Mutius E., Riedler J., Braun-Fahrlander C., Nowak D., Martinez F.D. Toll-like receptor 2 as a major gene for asthma in children of European farmers. J. Allergy Clin. Immunol. 2004, 113:482-488.
34. Reijmerink N.E., Bottema R.W., Kerkhof M., Gerritsen J., Stelma F.F., Thijs C., van Schayck C.P., Smit H.A., Brunekreef B., Koppelman G.H., Postma D.S. TLR-related pathway analysis: novel gene-gene interactions in the development of asthma and atopy. Allergy 2010, 65:199-207.
35. Clarke T.B., Davis K.M., Lysenko E.S., Zhou A.Y., Yu Y., Weiser J.N. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat. Med. 2010, 16:228-231.
36. Eder W., Klimecki W., Yu L., von Mutius E., Riedler J., Braun-Fahrlander C., Nowak D., Holst O., Martinez F.D. Association between exposure to farming, allergies and genetic variation in CARD4/NOD1. Allergy 2006, 61:1117-1124.
37. Kabesch M., Peters W., Carr D., Leupold W., Weiland S.K., von Mutius E. Association between polymorphisms in caspase recruitment domain containing protein 15 and allergy in two German populations. J. Allergy Clin. Immunol. 2003, 111:813-817.
38. Reece P., Thanendran A., Crawford L., Tulic M.K., Thabane L., Prescott S.L., Sehmi R., Denburg J.A. Maternal allergy modulates cord blood hematopoietic progenitor Toll-like receptor expression and function. J. Allergy Clin. Immunol. 2011, 127:447-453.
39. Gupta G.K., Agrawal D.K. CpG oligodeoxynucleotides as TLR9 agonists: therapeutic application in allergy and asthma. BioDrugs 2010, 24:225-235.
40. Lachheb J., Dhifallah I.B., Chelbi H., Hamzaoui K., Hamzaoui A. Toll-like receptors and CD14 genes polymorphisms and susceptibility to asthma in Tunisian children. Tissue Antigens 2008, 71:417-425.
41. Stowell N.C., Seideman J., Raymond H.A., Smalley K.A., Lamb R.J., Egenolf D.D., Bugelski P.J., Murray L.A., Marsters P.A., Bunting R.A., Flavell R.A., Alexopoulou L., San Mateo L.R., Griswold D.E., Sarisky R.T., Mbow M.L., Das A.M. Long-term activation of TLR3 by poly(I:C) induces inflammation and impairs lung function in mice. Respir. Res. 2009, 10:43.
42. Mizel S.B., Honko A.N., Moors M.A., Smith P.S., West A.P. Induction of macrophage nitric oxide production by Gram-negative flagellin involves signaling via heteromeric Toll-like receptor 5/Toll-like receptor 4 complexes. J. Immunol. 2003, 170:6217-6223.
43. Lloyd C.M., Hawrylowicz C.M. Regulatory T cells in asthma. Immunity 2009, 31:438-449.
44. Shi Y.H., Shi G.C., Wan H.Y., Jiang L.H., Ai X.Y., Zhu H.X., Tang W., Ma J.Y., Jin X.Y., Zhang B.Y. Coexistence of Th1/Th2 and Th17/Treg imbalances in patients with allergic asthma. Chin. Med. J. (Engl.) 2011, 124:1951-1956.
45. Robinson D.S. The role of the T cell in asthma. J. Allergy Clin. Immunol. 2010, 126:1081-1091. (quiz 1092-1083).
46. Provoost S., Maes T., van Durme Y.M., Gevaert P., Bachert C., Schmidt-Weber C.B., Brusselle G.G., Joos G.F., Tournoy K.G. Decreased FOXP3 protein expression in patients with asthma. Allergy 2009, 64:1539-1546.
47. Vale-Pereira S., Todo-Bom A., Geraldes L., Schmidt-Weber C., Akdis C.A., Mota-Pinto A. FoxP3, GATA-3 and T-bet expression in elderly asthma. Clin. Exp. Allergy 2011, 41:490-496.
48. Braber S., Overbeek S.A., Koelink P.J., Henricks P.A., Zaman G.J., Garssen J., Kraneveld A.D., Folkerts G. CXCR2 antagonists block the N-Ac-PGP-induced neutrophil influx in the airways of mice, but not the production of the chemokine CXCL1. Eur. J. Pharmacol. 2011, 668:443-449.
49. de Kivit S., Saeland E., Kraneveld A.D., van de Kant H.J., Schouten B., van Esch B.C., Knol J., Sprikkelman A.B., van der Aa L.B., Knippels L.M., Garssen J., van Kooyk Y., Willemsen L.E. Galectin-9 induced by dietary synbiotics is involved in suppression of allergic symptoms in mice and humans. Allergy 2013, 67:343-352.
50. Chauhan S.K., Saban D.R., Lee H.K., Dana R. Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation. J. Immunol. 2009, 182:148-153.
51. Zhou L., Nazarian A.A., Smale S.T. Interleukin-10 inhibits interleukin-12 p40 gene transcription by targeting a late event in the activation pathway. Mol. Cell. Biol. 2004, 24:2385-2396.
52. Zhao Y., Yang J., Gao Y.D., Guo W. Th17 immunity in patients with allergic asthma. Int. Arch. Allergy Immunol. 2010, 151:297-307.
53. Forsythe P. Probiotics and lung diseases. Chest 2011, 139:901-908.